Abstract :
Increased sedation, somnolence, and sleep episodes seem to occur with several, if not all, dopamine agonists and dopaminergic treatment. Patients at risk of sleep episodes can be identified by well-chosen questions, and could be managed by appropriate measures including dose reduction.